Neogen Corp (NEOG)

Sector: Healthcare
Industry: In Vitro & In Vivo Diagnostic Substances
Country: United States
Exchange: NASDAQ
Market cap: $2.84B

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.

Latest financial period: May 31, 2026
Filed with the SEC: July 30, 2026
Estimated earnings date: October 6, 2026

Not currently ranked. Fewer than eight consecutive quarters are available.

Menu

Home

Compare

Next Earnings Reports

How this site works

Terms of use

About